496 related articles for article (PubMed ID: 32425645)
1. Use of convalescent plasma in COVID-19 patients in China.
Zhu M; Hu K; Zhu Z
Transfus Clin Biol; 2020 Aug; 27(3):168-169. PubMed ID: 32425645
[No Abstract] [Full Text] [Related]
2. Plasma from donors convalescent from SARS-CoV-2 infection-A matter of priorities.
Farrugia A
Transfus Clin Biol; 2020 Aug; 27(3):167-168. PubMed ID: 32563550
[No Abstract] [Full Text] [Related]
3. The convalescent sera option for containing COVID-19.
Casadevall A; Pirofski LA
J Clin Invest; 2020 Apr; 130(4):1545-1548. PubMed ID: 32167489
[No Abstract] [Full Text] [Related]
4. INFUSION OF CONVALESCENT PLASMA IS ASSOCIATED WITH CLINICAL IMPROVEMENT IN CRITICALLY ILL PATIENTS WITH COVID-19: A PILOT STUDY.
Olivares-Gazca JC; Priesca-Marín JM; Ojeda-Laguna M; Garces-Eisele J; Soto-Olvera S; Palacios-Alonso A; Izquierdo-Vega J; Chacon-Cano R; Arizpe-Bravo D; López-Trujillo MA; Cantero-Fortiz Y; Fernandez-Lara D; Ruiz-Delgado GJ; Ruiz-Argüelles GJ
Rev Invest Clin; 2020; 72(3):159-164. PubMed ID: 32584322
[TBL] [Abstract][Full Text] [Related]
5. Audio Interview: Capitalizing on Immune Responses to Covid-19.
Rubin EJ; Baden LR; Morrissey S
N Engl J Med; 2020 May; 382(21):e93. PubMed ID: 32433859
[No Abstract] [Full Text] [Related]
6. Convalescent Plasma: Promise for COVID-19 Pandemic.
Sheikh S; Baig MA
J Coll Physicians Surg Pak; 2020 Jun; 30(6):88. PubMed ID: 32723468
[No Abstract] [Full Text] [Related]
7. Position paper on the preparation of immune plasma to be used in the treatment of patients with COVID-19.
Accorsi P; Berti P; de Angelis V; De Silvestro G; Mascaretti L; Ostuni A;
Transfus Apher Sci; 2020 Aug; 59(4):102817. PubMed ID: 32532691
[TBL] [Abstract][Full Text] [Related]
8. Management of COVID-19 Virus Infection by Convalescent Plasma.
Cheraghali AM; Abolghasemi H; Eshghi P
Iran J Allergy Asthma Immunol; 2020 May; 19(S1):3-6. PubMed ID: 32534509
[TBL] [Abstract][Full Text] [Related]
9. The resurgence of convalescent plasma therapy.
The Lancet Haematology
Lancet Haematol; 2020 May; 7(5):e353. PubMed ID: 32359447
[No Abstract] [Full Text] [Related]
10. Coronavirus drugs: Using plasma from recovered patients as a treatment for COVID-19.
Alzoughool F; Alanagreh L
Int J Risk Saf Med; 2020; 31(2):47-51. PubMed ID: 32310190
[TBL] [Abstract][Full Text] [Related]
11. Convalescent Plasma and COVID-19.
Malani AN; Sherbeck JP; Malani PN
JAMA; 2020 Aug; 324(5):524. PubMed ID: 32530454
[No Abstract] [Full Text] [Related]
12. Active Therapy with Passive Immunotherapy May Be Effective in the Fight against COVID-19.
Morabito CJ; Gangadharan B
Clin Transl Sci; 2020 Sep; 13(5):835-837. PubMed ID: 32420691
[No Abstract] [Full Text] [Related]
13. Improved clinical symptoms and mortality among patients with severe or critical COVID-19 after convalescent plasma transfusion.
Xia X; Li K; Wu L; Wang Z; Zhu M; Huang B; Li J; Wang Z; Wu W; Wu M; Li W; Li L; Cai Y; Bosco B; Zhong A; Liu X; Lv T; Gan Z; Chen G; Pan Y; Liu C; Zhang K; Xu X; Wang C; Wang Q
Blood; 2020 Aug; 136(6):755-759. PubMed ID: 32573724
[TBL] [Abstract][Full Text] [Related]
14. Feasibility of a pilot program for COVID-19 convalescent plasma collection in Wuhan, China.
Li L; Yang R; Wang J; Lv Q; Ren M; Zhao L; Chen H; Xu H; Xie S; Xie J; Lin H; Li W; Fang P; Gong L; Wang L; Wu Y; Liu Z
Transfusion; 2020 Aug; 60(8):1773-1777. PubMed ID: 32491199
[TBL] [Abstract][Full Text] [Related]
15. A Randomized Open label Phase-II Clinical Trial with or without Infusion of Plasma from Subjects after Convalescence of SARS-CoV-2 Infection in High-Risk Patients with Confirmed Severe SARS-CoV-2 Disease (RECOVER): A structured summary of a study protocol for a randomised controlled trial.
Janssen M; Schäkel U; Djuka Fokou C; Krisam J; Stermann J; Kriegsmann K; Haberbosch I; Novotny JP; Weber S; Vehreschild M; Bornhäuser M; Bullinger L; Schmitt M; Liebregts T; Dreger P; Lorenz HM; Plaszczyca A; Bartenschlager R; Müller B; Kräusslich HG; Halama N; Jäger D; Schlenk RF; Leo A; Meuer S; Weigand MA; Motsch J; Merle U; Denkinger CM; Müller-Tidow C
Trials; 2020 Oct; 21(1):828. PubMed ID: 33023671
[TBL] [Abstract][Full Text] [Related]
16. Could Coronavirus Disease 2019 (COVID-19) Render Natural Immunity to Re-infections? A Spotlight on the Therapeutic Pipeline.
Abid MA; Nunley L; Abid MB
Front Immunol; 2020; 11():1294. PubMed ID: 32582221
[No Abstract] [Full Text] [Related]
17. Characteristics and serological patterns of COVID-19 convalescent plasma donors: optimal donors and timing of donation.
Li L; Tong X; Chen H; He R; Lv Q; Yang R; Zhao L; Wang J; Xu H; Liu C; Chen G; Chen S; Li C; Qiao J; Yang J; Wu Y; Liu Z
Transfusion; 2020 Aug; 60(8):1765-1772. PubMed ID: 32627216
[TBL] [Abstract][Full Text] [Related]
18. Convalescent Plasma Therapy in Patients With Severe or Life-Threatening COVID-19: A Metadata Analysis.
Rabelo-da-Ponte FD; Silvello D; Scherer JN; Ayala AR; Klamt F
J Infect Dis; 2020 Oct; 222(9):1575-1578. PubMed ID: 32777038
[No Abstract] [Full Text] [Related]
19. Anti-SARS-CoV-2 virus antibody levels in convalescent plasma of six donors who have recovered from COVID-19.
Zhang L; Pang R; Xue X; Bao J; Ye S; Dai Y; Zheng Y; Fu Q; Hu Z; Yi Y
Aging (Albany NY); 2020 Apr; 12(8):6536-6542. PubMed ID: 32320384
[TBL] [Abstract][Full Text] [Related]
20. Treatment of COVID-19: old tricks for new challenges.
Cunningham AC; Goh HP; Koh D
Crit Care; 2020 Mar; 24(1):91. PubMed ID: 32178711
[No Abstract] [Full Text] [Related]
[Next] [New Search]